research
conduct
last
year
reveal
host
cell
express
antivir
effector
molecul
inhibit
spread
certain
virus
interf
discret
step
viral
life
cycl
express
virusrestrict
factor
short
restrict
factor
constitut
frequent
induc
interferon
ifn
singl
restrict
factor
identifi
screen
approach
seek
determin
molecular
mechan
underli
specif
antivir
activ
recent
systemat
screen
ifninduc
antivir
effector
provid
detail
insight
full
restrict
factor
repertoir
host
cell
one
restrict
factor
uncov
screen
previous
identifi
cellular
protein
inhibit
releas
transmembran
protein
tetherin
appreci
tetherin
restrict
releas
sever
envelop
virus
recent
find
suggest
signific
contribut
tetherin
retroviru
control
experiment
infect
mice
tetherin
unusu
membran
topolog
basi
antivir
activ
tetherin
contain
two
membran
anchor
transmembran
domain
nterminu
ctermin
gpi
anchor
propos
latter
might
meet
criteria
transmembran
domain
gpi
anchor
consequ
two
membraneanchor
domain
tetherin
simultan
insert
plasma
membran
viral
membran
therebi
form
physic
connector
host
cell
viru
prevent
releas
progeni
particl
extracellular
space
import
tetherin
domain
organ
antivir
activ
highlight
two
observ
mutat
either
membraneanchor
domain
interfer
inhibit
viral
releas
artifici
tetherin
molecul
bear
sequenc
similar
wt
tetherin
exhibit
domain
organ
display
antivir
activ
order
ensur
effici
spread
tetherin
posit
cell
sever
virus
encod
protein
antagon
antivir
activ
tetherin
mainli
remov
tetherin
site
viral
bud
first
tetherin
antagonist
identifi
accessori
protein
vpu
vpu
antagon
tetherin
remov
plasma
membran
process
depend
interact
transmembran
domain
vpu
tetherin
allow
vpudepend
alter
tetherin
traffick
thu
vpu
interact
tetherin
prevent
transport
newli
synthes
recycl
tetherin
plasma
membran
addit
vpu
remov
tetherin
plasma
membran
although
rel
low
effici
induc
tetherin
ubiquitin
degrad
endolysosom
howev
contribut
process
tetherin
antagon
vpu
seem
minor
final
notabl
speci
specif
differ
amino
acid
sequenc
tetherin
transmembran
domain
alter
suscept
antagon
vpu
underlin
tetherin
interact
vpu
highli
specif
glycoprotein
gp
ebolavirus
marburgvirus
member
filovirida
famili
highli
pathogen
human
also
antagon
tetherin
allow
effici
releas
retro
filoviruslik
particl
tetherin
transfect
cell
addit
tetherin
antagon
gp
like
respons
modest
absent
inhibit
releas
authent
ebola
viru
ebov
tetherin
notabl
differ
tetherin
antagon
vpu
ebovgp
report
direct
interact
subunit
ebovgp
tetherin
document
might
dispens
tetherin
antagon
sinc
ebovgp
unlik
vpu
counteract
artifici
tetherin
similarli
ebovgp
vpu
antagon
tetherin
orthologu
differ
mammalian
speci
moreov
ebovgp
contrast
vpu
reduc
tetherin
express
cell
surfac
remov
tetherin
lipid
raft
sum
ebovgp
vpu
employ
markedli
differ
mechan
counteract
tetherin
determin
gp
govern
tetherin
counteract
larg
unclear
lassa
viru
lasv
member
arenavirida
famili
like
ebov
highli
pathogen
human
inhibit
tetherin
viral
glycoprotein
gpc
antagon
tetherin
previou
studi
construct
chimera
marburg
viru
gp
marvgp
lasvgpc
order
identifi
determin
viral
assembl
employ
lasvgpcmarvgp
chimera
newli
construct
lasvgpcebovgp
chimera
map
domain
import
tetherin
counteract
found
cytoplasm
tail
ebov
marvgp
integr
fusion
peptid
sequenc
ebovgp
dispens
tetherin
counteract
exchang
transmembran
cytoplasm
domain
ebovgpmarvgp
lasvgpc
imped
tetherin
counteract
filoviru
gp
transfer
tetherin
antagon
lasvgpc
indic
determin
gp
govern
tetherin
antagon
complex
sought
employ
chimer
ebovmarv
lasv
glycoprotein
identifi
domain
import
tetherin
counteract
prerequisit
studi
first
determin
tetherin
counteract
wt
protein
express
ebovgp
marvgp
lasvgpc
ctermin
antigen
tag
readili
detect
western
blot
analysi
transfect
cell
figur
expect
precursor
glycoprotein
matur
ctermin
transmembran
unit
gener
upon
process
precursor
host
cell
proteas
detect
larg
exhibit
expect
molecular
weight
moreov
lentivir
vector
pseudotyp
glycoprotein
without
tag
abl
effici
transduc
cell
appreci
transduct
observ
upon
inocul
cell
vector
bear
glycoprotein
figur
thu
construct
avail
studi
allow
robust
glycoprotein
express
glycoprotein
abl
mediat
effici
host
cell
entri
expect
order
determin
whether
glycoprotein
abl
counteract
tetherin
previous
describ
viruslik
particl
system
employ
system
base
gag
suffici
drive
bud
bud
inhibit
tetherin
lasvgpc
previous
character
experiment
setup
effici
releas
gag
supernat
cultur
cell
observ
absenc
tetherin
releas
modul
coexpress
vpu
ebovgp
marvgp
lasvgpc
figur
concord
publish
data
contrast
coexpress
tetherin
markedli
reduc
gag
releas
effect
could
partial
rescu
express
vpu
ebovgp
marvgp
lasvgpc
figur
keep
previou
studi
thu
filovir
gp
lasvgpc
function
tetherin
antagonist
context
gagdepend
bud
mutagen
analysi
glycoprotein
might
reveal
domain
requir
tetherin
antagon
cytoplasm
tail
ebovgp
marvgp
compris
four
eight
amino
acid
respect
previous
shown
import
robust
gpdriven
viruscel
fusion
role
tetherin
antagon
gp
determin
express
ebovgp
marvgp
mutant
lack
cytoplasm
tail
figur
readili
detect
antibodi
specif
tag
although
somewhat
less
effici
express
wt
protein
figur
similarli
mutant
incorpor
viruslik
particl
vlp
although
slightli
reduc
effici
compar
wt
counterpart
shown
lentivir
vector
bear
without
tag
show
markedli
reduc
capac
transduc
cell
compar
vector
equip
wt
protein
figur
keep
document
import
cytoplasm
tail
gpdriven
entri
despit
modestli
reduc
express
readili
abl
counteract
tetherin
figur
indic
cytoplasm
tail
requir
tetherin
antagon
filovir
glycoprotein
next
examin
role
transmembran
domain
filoviru
gp
tetherin
counteract
western
blot
analys
antibodi
reveal
exchang
transmembran
domain
ebovgpmarvgp
lasvgpc
figur
compat
robust
express
figur
keep
publish
data
although
express
mlm
reduc
compar
express
wt
marvgp
weak
express
figur
shown
mutant
ele
observ
upon
detect
antibodi
direct
tag
howev
signal
compar
detect
wt
ebovgp
observ
express
ele
tag
visual
ebovgp
specif
antibodi
figur
suggest
mutant
readili
express
order
analyz
whether
exchang
transmembran
domain
modul
cellular
local
glycoprotein
variant
studi
employ
spin
disk
confoc
microscopi
total
intern
reflect
fluoresc
tirf
microscopi
stain
cell
antibodi
analysi
confoc
microscopi
reveal
major
chang
local
mutant
lml
ele
lel
respect
wt
protein
although
rel
low
percentag
cell
posit
mutant
ele
figur
moreov
tirf
microscopi
show
wt
protein
mutant
lml
ele
lel
appreci
express
plasma
membran
figur
contrast
mutant
mlm
predominantli
local
within
cell
although
plasma
membran
local
detect
keep
express
ele
lel
lml
lesser
degre
mlm
plasma
membran
mutant
effici
incorpor
vlp
shown
thu
exchang
transmembran
domain
ebovmarvgp
lasvgpc
larg
compat
glycoprotein
express
cell
surfac
particl
incorpor
despit
readili
detect
express
particl
incorpor
glycoprotein
mutant
exchang
transmembran
domain
none
mutant
without
tag
abl
appreci
drive
viruscel
fusion
figur
indic
appropri
transmembran
domain
essenti
gp
function
viral
entri
similarli
none
transmembran
domain
mutant
abl
counteract
tetherin
thu
introduct
transmembran
domain
ebovgp
marvgp
lasvgpc
confer
tetherin
antagon
lasvgpc
revers
exchang
abrog
tetherin
counteract
ebovgp
marvgp
figur
result
indic
transmembran
domain
glycoprotein
studi
essenti
abil
mediat
viruscel
fusion
moreov
find
show
transmembran
domain
ebovgp
marvgp
requir
tetherin
counteract
suffici
confer
tetherin
antagon
heterolog
glycoprotein
find
transmembran
domain
filoviru
gp
essenti
tetherin
antagon
figur
prompt
us
investig
whether
specif
amino
acid
transmembran
domain
identifi
requir
tetherin
counteract
mutat
residu
transmembran
domain
ebovgp
conserv
among
filoviru
gp
mutant
figur
moreov
observ
chimer
gp
lost
abil
drive
viruscel
fusion
capac
counteract
tetherin
figur
b
suggest
two
activ
might
depend
function
element
gp
therefor
ask
mutat
conserv
residu
fusion
peptid
fp
ebovgp
block
membran
fusion
thu
viral
entri
target
cell
might
also
interfer
tetherin
antagon
mutant
gp
mutant
effici
express
cell
although
express
mutant
slightli
reduc
compar
express
ebovgp
wt
figur
similarli
gp
mutant
effici
incorpor
vlp
shown
mutat
fp
invari
reduc
abil
gp
drive
viruscel
fusion
keep
publish
data
alter
transmembran
domain
littl
mutant
inhibitori
effect
mutant
figur
notabl
mutant
abl
counteract
tetherin
figur
indic
neither
capac
effici
drive
membran
fusion
presenc
sever
conserv
amino
acid
transmembran
domain
requir
tetherin
antagon
filoviru
gp
antagon
tetherin
vlpbase
system
like
allow
spread
authent
filovirus
tetherinposit
cell
howev
domain
gp
requir
tetherin
antagon
remain
elus
previou
work
demonstr
portion
ebovgp
interact
tetherin
analyz
whether
domain
particular
transmembran
domain
fusion
peptid
contribut
tetherin
counteract
ebov
marvgp
show
presenc
authent
transmembran
domain
ebovgp
marvgp
requir
gpdriven
viruscel
fusion
tetherin
antagon
howev
exchang
transmembran
domain
suffici
transfer
tetherin
antagon
heterolog
viral
glycoprotein
addit
demonstr
capac
gp
mediat
viruscel
fusion
requir
tetherin
antagon
result
suggest
transmembran
domain
contribut
tetherin
antagon
filoviru
gp
domain
also
play
role
filovirus
ebov
marv
induc
sever
frequent
lethal
hemorrhag
fever
infect
human
patient
nonhuman
primat
gp
virus
mediat
entri
host
cell
facilit
transduct
broad
rang
target
cell
upon
incorpor
retrovir
rhabdovir
vector
addit
filoviru
gp
rescu
bud
driven
filoviru
gag
inhibit
tetherin
rel
robust
releas
ebov
tetherin
express
cell
suggest
gp
also
protect
authent
filovirus
tetherin
antivir
action
contrast
spread
authent
lasv
inhibit
tetherin
lasvgpc
filoviru
gp
class
membran
fusion
counteract
tetherin
vlpbase
system
keep
result
obtain
present
studi
domain
filovir
gp
lasvgpc
respons
differenti
abil
counteract
tetherin
unknown
therefor
domainswap
filovir
gp
lasvgpc
well
alter
function
import
domain
gp
could
suitabl
way
detect
determin
gp
control
tetherin
antagon
first
assess
whether
short
cytoplasm
tail
ebovgp
marvgp
requir
tetherin
counteract
previous
document
cytoplasm
tail
dispens
gp
express
trimer
intracellular
transport
incorpor
filoviruslik
particl
howev
delet
cytoplasm
tail
alter
gp
glycosyl
recognit
neutral
antibodi
impair
host
cell
entri
filoviruslik
particl
result
confirm
delet
cytoplasm
tail
dispens
robust
gp
express
particl
incorpor
shown
imped
effici
gpdriven
viruscel
fusion
cytoplasm
tail
dispens
tetherin
counteract
keep
previou
result
show
amino
acid
cytoplasm
tail
believ
import
lipid
raft
local
gp
dispens
tetherin
counteract
thu
cytoplasm
tail
gp
seem
requir
gp
function
viral
entri
dispens
counteract
tetherin
viral
releas
analysi
chimera
lasvgpc
marvgp
previous
demonstr
presenc
authent
transmembran
domain
marvgp
requir
transport
gp
multivesicular
bodi
contain
elev
level
viral
matrix
protein
particl
incorpor
gp
result
confirm
previous
document
observ
exchang
transmembran
domain
marvgp
lasvgp
compat
robust
express
result
chimera
although
reduc
level
mutant
mlm
rel
marvgp
wt
detect
cell
might
partial
account
lack
tetherin
counteract
mutant
show
appli
ebovgp
addit
result
indic
exchang
transmembran
domain
interfer
gp
local
cell
membran
site
tetherin
unfold
antivir
activ
mutant
mlm
except
nevertheless
chimer
gp
fail
mediat
viruscel
fusion
despit
effici
incorpor
lentivir
vector
data
shown
similarli
chimer
protein
includ
lasvgpc
variant
harbor
filoviru
gpderiv
transmembran
domain
fail
counteract
tetherin
contrast
residu
within
ebovgp
transmembran
domain
conserv
among
filoviru
gp
dispens
tetherin
counteract
find
indic
transmembran
domain
contribut
exclus
determin
tetherin
counteract
moreov
suggest
role
transmembran
domain
tetherin
antagon
filovir
gp
might
due
potenti
impact
gp
conform
cellular
local
rather
presenc
specif
amino
acid
within
domain
subunit
filoviru
gp
contain
function
element
drive
viruscel
fusion
includ
fusion
peptid
peptid
insert
target
cell
membran
viruscel
fusion
integr
essenti
viral
infect
analysi
chimer
gp
suggest
capac
gp
drive
effici
host
cell
entri
might
prerequisit
tetherin
counteract
opposit
conclus
could
drawn
character
gp
mutant
without
cytoplasm
tail
order
assess
whether
abil
mediat
viruscel
fusion
gener
integr
fusion
peptid
particular
import
tetherin
counteract
analyz
ebovgp
mutant
amino
acid
chang
fusion
peptid
respect
gp
mutant
robustli
express
fail
drive
effici
viruscel
fusion
observ
match
result
obtain
previou
studi
demonstr
exchang
fusion
peptid
compat
robust
virion
incorpor
gp
gpdriven
viruscel
fusion
particular
singl
mutant
tripl
mutant
analyz
present
studi
effici
incorpor
vsv
vector
fail
drive
effici
viru
cell
fusion
fusion
peptid
mutant
test
abl
counteract
tetherin
indic
integr
fusion
peptid
abil
gp
effici
drive
viruscel
fusion
dispens
tetherin
counteract
human
embryon
kidney
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
antibiot
cell
grown
day
prior
transfect
cell
seed
densiti
well
format
flask
cell
transfect
calcium
phosphat
method
use
dna
total
one
well
plate
dna
total
transfect
flask
medium
exchang
eight
h
post
transfect
plasmid
encod
gag
vpu
lasvgpc
ebovgp
ebovgp
ctermin
marvgp
human
tetherin
deriv
vector
describ
previous
plasmid
encod
chimera
lasvgpc
marvgp
transmembran
domain
exchang
mutant
lml
mlm
ebovgp
marvgp
delet
cytoplasm
domain
cd
mutant
also
describ
previous
addit
chimer
gp
transmembran
domain
exchang
lasvgpc
ebovgp
mutant
ele
lel
well
glycoprotein
ctermin
tag
gener
pcr
pcr
product
insert
pcagg
express
vector
restrict
site
ecori
xhoi
ecori
nhei
ele
lel
xmai
nhei
ebovgp
mutant
point
mutat
fp
tm
also
gener
pcrbase
mutagenesi
insert
via
xbai
mlui
pcagg
integr
pcramplifi
sequenc
analyz
autom
sequenc
test
express
level
glycoprotein
analyz
respect
express
plasmid
transfect
cell
seed
plate
h
post
transfect
cell
harvest
lyse
glycoprotein
express
cell
lysat
detect
western
blot
detect
mous
anti
antibodi
invitrogen
carlsbad
ca
usa
use
dilut
altern
mous
antiebovgp
antibodi
use
dilut
order
analyz
tetherin
antagon
previous
describ
viruslik
particl
system
use
cell
seed
plate
cotransfect
plasmid
encod
gag
tetherin
respect
tetherin
antagonist
ratio
fortyeight
hour
transfect
supernat
clear
debri
rpm
pellet
h
sucros
cushion
rpm
pellet
vlp
well
produc
cell
lyse
boil
sdsload
buffer
subsequ
analyz
western
blot
gag
protein
detect
hybridoma
supernat
goat
anti
mousehrp
antibodi
dianova
hamburg
germani
use
commerci
avail
kit
ge
healthcar
chalfont
st
gile
uk
gener
pseudotyp
carri
differ
glycoprotein
includ
vsvg
filovir
gp
lasvgpc
chimer
gp
glycoprotein
control
previous
describ
protocol
use
briefli
cell
seed
flask
transfect
glycoprotein
express
plasmid
ratio
h
post
transfect
supernat
harvest
pass
pores
filter
subsequ
transduct
cell
seed
plate
densiti
cellswel
cell
transduc
vector
contain
supernat
medium
exchang
h
post
transduct
transduct
effici
measur
determin
luciferas
activ
cell
lysat
h
post
infect
use
commerci
avail
kit
promega
madison
wi
usa
cell
seed
mm
glass
bottom
cultur
dish
willcodish
amsterdam
netherland
calcium
phosphat
transfect
glycoprotein
express
plasmid
empti
plasmid
control
h
post
transfect
cell
fix
pfa
min
permeabil
saponin
min
rt
subsequ
cell
stain
use
dilut
specif
antibodi
invitrogen
dilut
goat
antimous
alexa
fluor
conjug
secondari
antibodi
molecular
probe
invitrogen
tirf
microscopi
conduct
nikon
tie
microscop
use
object
na
essenti
previous
describ
confoc
imag
sampl
transfect
stain
tirf
mount
dapi
contain
mowiol
spin
disc
confoc
microscopi
done
nikon
tie
equip
perkinelm
ultraview
vox
system
imag
analyz
voloc
packag
perkin
elmer
waltham
usa
result
suggest
sever
determin
filoviru
gp
might
control
tetherin
counteract
futur
studi
must
address
whether
function
domain
subunit
like
receptor
bind
domain
mediat
interact
play
role
tetherin
counteract
similarli
interest
investig
ebovgp
although
abl
counteract
wt
artifici
tetherin
fail
enhanc
releas
lasvlik
particl
observ
highlight
determin
govern
tetherin
inhibit
viral
releas
counteract
filovir
glycoprotein
complex
